Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    19451549 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive
Conditions: Metastatic Cancer That Express the MAGE-A3-HLA A01 Antigen;   Metastatic Melanoma That Express the MAGE-A3-HLA A01 Antigen;   Metastatic Cancer
Interventions: Drug: Aldesleukin;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: Anti-MAGE-A3 HLAA* 01-restricted TCR
2 Recruiting To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor (TCR) Affinity Enhancing Specific T Cell in Solid Tumors
Conditions: Bone Sarcoma;   Soft Tissue Sarcoma;   Melanoma;   Liver Cancer;   Esophageal Cancer;   Breast Cancer;   Thyroid Cancer;   Ovarian Cancer
Interventions: Drug: Cyclophosphamide;   Biological: TAEST16001

Study has passed its completion date and status has not been verified in more than two years.